Growth Metrics

Fulgent Genetics (FLGT) Shares Outstanding (Weighted Average) (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Shares Outstanding (Weighted Average) for 11 consecutive years, with $30.8 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 1.79% to $30.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.8 million through Dec 2025, up 1.79% year-over-year, with the annual reading at $30.8 million for FY2025, 1.79% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $30.8 million in Q4 2025 for Fulgent Genetics, roughly flat from $30.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $30.8 million in Q1 2025 to a low of $28.8 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $30.0 million across 5 years, with a median of $30.1 million in 2022.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 36.16% in 2021 and later decreased 2.31% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $29.4 million in 2021, then rose by 2.34% to $30.1 million in 2022, then dropped by 1.04% to $29.8 million in 2023, then increased by 1.51% to $30.2 million in 2024, then increased by 1.79% to $30.8 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for FLGT at $30.8 million in Q4 2025, $30.7 million in Q3 2025, and $30.7 million in Q2 2025.